Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What are regulatory T cells (Treg) regulating in cancer and why?
Theresa L. Whiteside
Seminars in Cancer Biology (2012) Vol. 22, Iss. 4, pp. 327-334
Open Access | Times Cited: 264

Showing 1-25 of 264 citing articles:

The roles of TGFβ in the tumour microenvironment
Michael W. Pickup, Sergey V. Novitskiy, Harold L. Moses
Nature reviews. Cancer (2013) Vol. 13, Iss. 11, pp. 788-799
Open Access | Times Cited: 813
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero, Gustav Gaudernack, Winald R. Gerritsen, et al.
Nature Reviews Clinical Oncology (2014) Vol. 11, Iss. 9, pp. 509-524
Open Access | Times Cited: 711
Forkhead box proteins: tuning forks for transcriptional harmony
Eric W.‐F. Lam, Jan J. Brosens, Ana Gomes, et al.
Nature reviews. Cancer (2013) Vol. 13, Iss. 7, pp. 482-495
Closed Access | Times Cited: 639
A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods
Marialaura Madrigal, K. S. Rao, Neil H Riordan
Journal of Translational Medicine (2014) Vol. 12, Iss. 1
Open Access | Times Cited: 555
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
Belal Chaudhary, Eyad Elkord
Vaccines (2016) Vol. 4, Iss. 3, pp. 28-28
Open Access | Times Cited: 437
Emerging cytokine networks in colorectal cancer
Nathaniel R. West, Sarah McCuaig, Fanny Franchini, et al.
Nature reviews. Immunology (2015) Vol. 15, Iss. 10, pp. 615-629
Closed Access | Times Cited: 354
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
Panagiotis Balermpas, Yvonne Michel, Jens Wagenblast, et al.
British Journal of Cancer (2013) Vol. 110, Iss. 2, pp. 501-509
Open Access | Times Cited: 290
Natural and Induced T Regulatory Cells in Cancer
Dennis O. Adeegbe, Hiroyoshi Nishikawa
Frontiers in Immunology (2013) Vol. 4
Open Access | Times Cited: 230
T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
Christina Paluskievicz, Xuefang Cao, Reza Abdi, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 216
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
Sacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet, et al.
Journal for ImmunoTherapy of Cancer (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 204
Periodontal disease and risk of all cancers among male never smokers: an updated analysis of the Health Professionals Follow-up Study
Dominique S. Michaud, Karl T. Kelsey, Evangelos Papathanasiou, et al.
Annals of Oncology (2016) Vol. 27, Iss. 5, pp. 941-947
Open Access | Times Cited: 199
Cancer in kidney transplant recipients
Eric Au, Germaine Wong, Jeremy R. Chapman
Nature Reviews Nephrology (2018) Vol. 14, Iss. 8, pp. 508-520
Closed Access | Times Cited: 195
YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
Xuhao Ni, Jin‐Hui Tao, Joseph Barbi, et al.
Cancer Discovery (2018) Vol. 8, Iss. 8, pp. 1026-1043
Open Access | Times Cited: 185
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
Saskia J. Santegoets, Eveline M. Dijkgraaf, Alessandra Battaglia, et al.
Cancer Immunology Immunotherapy (2015) Vol. 64, Iss. 10, pp. 1271-1286
Open Access | Times Cited: 179
Hypoxia Enhances Immunosuppression by Inhibiting CD4+ Effector T Cell Function and Promoting Treg Activity
Astrid M. Westendorf, Kathrin Skibbe, Alexandra Adamczyk, et al.
Cellular Physiology and Biochemistry (2017) Vol. 41, Iss. 4, pp. 1271-1284
Open Access | Times Cited: 171
Targeting tumor microenvironment in ovarian cancer: Premise and promise
Yuting Jiang, Chengdi Wang, Shengtao Zhou
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1873, Iss. 2, pp. 188361-188361
Closed Access | Times Cited: 163
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4327-4347
Open Access | Times Cited: 125
Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review
Seyed Ali Aghapour, Mehdi Torabizadeh, Seyed Sobhan Bahreiny, et al.
Iranian Journal of Blood and Cancer (2024) Vol. 16, Iss. 2, pp. 84-101
Closed Access | Times Cited: 32
Immune system: a double-edged sword in cancer
Bodduluru Lakshmi Narendra, Kasala Eshvendar Reddy, S. Shantikumar, et al.
Inflammation Research (2013) Vol. 62, Iss. 9, pp. 823-834
Closed Access | Times Cited: 179
Targeting T cells to tumor cells using bispecific antibodies
Stanley R. Frankel, Patrick A. Baeuerle
Current Opinion in Chemical Biology (2013) Vol. 17, Iss. 3, pp. 385-392
Closed Access | Times Cited: 165
Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
Seema Gupta, Amrita Roy, Bilikere S. Dwarakanath
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 159
Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites
Powell Perng, Michael Lim
Frontiers in Oncology (2015) Vol. 5
Open Access | Times Cited: 158
Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression
Antje Sucker, Fang Zhao, Birgit Real, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 24, pp. 6593-6604
Open Access | Times Cited: 158
FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity
Theresa L. Whiteside
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 4, pp. 353-363
Open Access | Times Cited: 151
The tumour microenvironment and immune milieu of cholangiocarcinoma
Luca Fabris, María J. Perugorria, Joachim C. Mertens, et al.
Liver International (2019) Vol. 39, Iss. S1, pp. 63-78
Open Access | Times Cited: 143
Page 1 - Next Page

Scroll to top